Your browser doesn't support javascript.
loading
Extent of radiological response does not reflect survival in primary central nervous system lymphoma.
van der Meulen, Matthijs; Postma, Alida A; Smits, Marion; Bakunina, Katerina; Minnema, Monique C; Seute, Tatjana; Cull, Gavin; Enting, Roelien H; van der Poel, Marjolein; Stevens, Wendy B C; Brandsma, Dieta; Beeker, Aart; Doorduijn, Jeanette K; Issa, Samar; van den Bent, Martin J; Bromberg, Jacoline E C.
Afiliación
  • van der Meulen M; Department of Neuro-Oncology, Erasmus MC Cancer Institute, Brain Tumor Center, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Postma AA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, School for Mental Health and Sciences, Maastricht, The Netherlands.
  • Smits M; Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, Brain Tumor Center, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Bakunina K; Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Minnema MC; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Seute T; Department of Neurology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Cull G; Haematology Department, Sir Charles Gairdner Hospital and PathWest Laboratory Medicine, Nedlands, Australia.
  • Enting RH; University of Western Australia, Crawley, Australia.
  • van der Poel M; Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Stevens WBC; Department of Hematology, University Medical Center, Maastricht, The Netherlands.
  • Brandsma D; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Beeker A; Department of Neuro-Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Doorduijn JK; Department of Hematology, Spaarne Gasthuis, Haarlem, The Netherlands.
  • Issa S; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • van den Bent MJ; Department of Haematology, Middlemore Hospital, Auckland, New Zealand.
  • Bromberg JEC; Department of Neuro-Oncology, Erasmus MC Cancer Institute, Brain Tumor Center, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Neurooncol Adv ; 3(1): vdab007, 2021.
Article en En | MEDLINE | ID: mdl-33615224
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Neurooncol Adv Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Neurooncol Adv Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido